Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Bioinformatics Market Potential

Vaccine Research & Development 2009

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

New Products

Advanced Wound Management Pipeline Technology and Market Forecasts to 2015

Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Brazil Orthopedic Devices Market Analysis and Forecasts to 2015

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Canada Medical Equipment Market Analysis and Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015

Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management

BioPortfolio | Datamonitor Healthcare Reports | Stakeholder Opinions Endometriosis Scientific clarity will unlock market potential

Stakeholder Opinions Endometriosis Scientific clarity will unlock market potential

Endometriosis is a painful, menstrual-related disorder that is thought to affect approximately 10% of the female population of reproductive age. Despite this large patient potential, growth of the endometriosis market has been limited by low levels of investment, poor awareness among physicians and the public, problematic diagnosis, and lack of effective therapies.

Scope

Review of treatments and players in the seven major markets including their strategies for success. Movement of patients, depending on their treatment goal, through the referral and the treatment pathway. Overview of the pipeline including coverage of each of the novel mechanisms of action currently being explored. Identification of the unmet need, supported by international opinion leader insight.

Highlights

Supporting celebrity spokespeople is a useful strategy for pharmaceutical companies to adopt in the endometriosis market in order to destigmatize the disease and expand the patient population, as witnessed in the erectile dysfunction and osteoporosis markets. Imaging techniques, in particular ultrasonography, have the potential to become the new gold-standard diagnostic procedure. Biomolecular and genetic diagnostic tests, to replace CA-125, would be well received by physicians and several are being trialed currently. In the current litigious climate and given the return on investment based on the potential patient population, opinion leaders advise that manufacturers of new products would be justified in pursuing a specific endometriosis label.

Reasons to Purchase

Quantify the number of reproductively aged women with endometriosis in the general population and in gynecologic populations in the US, 5EU, and Japan Understand opinion leaders' views on topical issues and unmet need in the endometriosis market. Assess the competitive environment upon launch of a product based on the analysis of key pipeline products and R&D strategies.

19-Dec-07 PDF & SlidePack Pages: 139

Table of Contents
Price: $3,800.00 / €2,539.92

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions